[Future and limits of immunohemotherapy. Great possibilities with apheresis].
Norda
R
R
Kliniken för transfusionsmedicin och immunhemoterapi, Regionsjukhuset, Orebro.
Lundkvist
I
I
Söderström
T
T
D001781:Blood Component Removal / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends; D005069:Evaluation Studies as Topic; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects; D007937:Leukapheresis / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends; D010951:Plasma Exchange / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends; D010956:Plasmapheresis / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends; D013548:Sweden
D016756:Immunoglobulins, Intravenous
Framtid och begränsningar för immunhemoterapi. Stora möjligheter med aferesbehandling.